Ken Griffin Atai Life Sciences N.V. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Citadel Advisors LLC holds 58,300 shares of ATAI stock, worth $69,377. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,300
Previous 9,200
533.7%
Holding current value
$69,377
Previous $12,000
458.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ATAI
# of Institutions
87Shares Held
12.4MCall Options Held
77.8KPut Options Held
50.3K-
Morgan Stanley New York, NY3.04MShares$3.62 Million0.0% of portfolio
-
Walleye Capital LLC Plymouth, MN2.26MShares$2.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.56 Million0.0% of portfolio
-
Brown University719KShares$855,0150.36% of portfolio
-
Round Table Services, LLC704KShares$837,7600.46% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $197M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...